| Online-Ressource |
Verfasst von: | Betge, Johannes [VerfasserIn]  |
| Chi-Kern, Jing [VerfasserIn]  |
| Schulte, Nadine [VerfasserIn]  |
| Belle, Sebastian [VerfasserIn]  |
| Gutting, Tobias [VerfasserIn]  |
| Burgermeister, Elke [VerfasserIn]  |
| Jesenofsky, Ralf [VerfasserIn]  |
| Ebert, Matthias [VerfasserIn]  |
| Härtel, Nicolai [VerfasserIn]  |
Titel: | A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax) |
Verf.angabe: | Johannes Betge, Jing Chi-Kern, Nadine Schulte, Sebastian Belle, Tobias Gutting, Elke Burgermeister, Ralf Jesenofsky, Martin Maenz, Ulrich Wedding, Matthias P. Ebert and Nicolai Haertel |
E-Jahr: | 2018 |
Jahr: | 18 July 2018 |
Fussnoten: | Gesehen am 04.09.2018 |
Titel Quelle: | Enthalten in: BMC cancer |
Ort Quelle: | London : BioMed Central, 2001 |
Jahr Quelle: | 2018 |
Band/Heft Quelle: | 18(2018) Artikel-Nummer 747, 7 Seiten |
ISSN Quelle: | 1471-2407 |
Abstract: | In the group of elderly patients (≥70 years) with metastatic pancreatic ductal adenocarcinoma (mPDAC), it is not known who benefits from intensive 1st line nab-paclitaxel/gemcitabine (nab-p/gem) combination chemotherapy or who would rather suffer from increased toxicity. We aim to determine whether treatment individualization by comprehensive geriatric assessments (CGAs) improves functional outcome of the patients. |
DOI: | doi:10.1186/s12885-018-4665-2 |
URL: | kostenfrei: Volltext: http://dx.doi.org/10.1186/s12885-018-4665-2 |
| kostenfrei: Volltext: https://doi.org/10.1186/s12885-018-4665-2 |
| DOI: https://doi.org/10.1186/s12885-018-4665-2 |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1580646735 |
Verknüpfungen: | → Zeitschrift |
|
|
| |
Lokale URL UB: | Zum Volltext |
¬A¬ multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax) / Betge, Johannes [VerfasserIn]; 18 July 2018 (Online-Ressource)